- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05334342
Low-GI Diet Vs High-GI Diet in Individuals with SCI
Two Birds with One Stone: Impact of a Low Glycemic Index Diet on Postprandial Hypotension and Glucose Metabolism in Individuals with Spinal Cord Injury
Study Overview
Status
Intervention / Treatment
Detailed Description
Participants will first come for a screening visit one time, lasting a total of 2.5hours. For this screening visit, each participant will need to fast for 12 hours(go 12 hours without eating from the last meal). During this study visit, each participant will be going through the following tests:
- Urine pregnancy tests (for females)
- Medical History Questionnaire: It will take about 10 minutes, and participants will fill out a 1-page questionnaire about their medical history and medication use
- Each participant will consume a semi-liquid meal within 5 minutes
- Each participant's blood pressure will be measured every 5 minutes before eating, for 15 minutes, and for 2 hours after eating.
After the screening visit, each participant will be coming for study visits on 2 separate mornings, separated by at least 1 week. On these two mornings, the participant will be randomly picked (like the flip of a coin) by a computer to eat the low-glycemic index meal or high-glycemic index meal. After the visit in the morning, the participant will be sent home wearing a blood pressure monitor and blood sugar monitor, along with study meals the participant will be eating for 3 days.
These procedures and tests will be made during these 3-day periods:
At UAB during the morning visit:
- Meal tolerance test: Firstly, a nurse will place an intravenous catheter in the participant's arm to allow blood draws. The participant will be asked to eat the study meal given by the investigators, and provide several blood samples (immediately before and 10, 30, 60, 90, and 120 minutes after glucose ingestion). The total amount of blood taken will be about 3 tablespoons.
- Participant's blood pressure will be measured every 5 minutes before eating, for 15 minutes, and for 2 hours after eating.
After participant goes home from UAB:
- Before the participant leaves for home, the investigator(s) will fit a wearable blood pressure monitor on his/her arm and insert a continuous glucose monitor in the back of the other arm.
- The blood pressure monitors will be programmed to measure blood pressure every 15 minutes during the daytime and hourly during nighttime. The daytime and nighttime cycle will be set according to each participant's sleep/wake pattern. Participants will need to keep the monitored arm steady and at heart level during each blood pressure reading.
- Each participant will be provided with meals for 3 days. They will be eating all and only the meals the investigators provide during these 3 days.
- Each participant will be filling out a checklist to record the time of each meal consumed.
- Each participant will be asked questions regarding their daily activity for the past 3 days for the investigators to estimate their activity level. The investigators will use the Physical Activity Recall Assessment for People with Spinal Cord Injury (PARA-SCI) questionnaire. This takes about 30 minutes and will be done over the phone
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Chronic SCI, At least 1 year after injury, Injury level between Cervical 4 and Lumbar 2, with an American Spinal Injury Association (ASIA) Impairment Scale classification of A-D
Exclusion Criteria:
- pregnancy or breastfeeding, type 1 or insulin-dependent type 2 diabetes, a recent change in the use of any medications, previous diagnosis of heart diseases and/or stroke, or neurological impairment other than SCI.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Low-GI Diet
Low Glycemic Index Diet
|
Participants will be given a low glycemic index diet
|
|
Active Comparator: High-GI Diet
High Glycemic Index Diet
|
Participants will be given a high glycemic index diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-meal Systolic Blood Pressure Change- Visit 1
Time Frame: In-lab testing - Visit 1 - Day 1
|
SBP will be measured in the temperature-controlled, quiet, dimly lit room.
Measurements will be taken using an automated sphygmomanometer every 5 minutes for 20 minutes before, and for 120 minutes after meal intake, with the participant in a sitting position.
Investigators will identify the nadir of SBP during the 120-minute postprandial period.
The magnitude of the drop in SBP will be calculated by subtracting the nadir value from the resting baseline average value.
|
In-lab testing - Visit 1 - Day 1
|
|
Post-meal Systolic Blood Pressure Change- Visit 2
Time Frame: In-lab testing - Visit 2 - Day 1
|
SBP will be measured in the temperature-controlled, quiet, dimly lit room.
Measurements will be taken using an automated sphygmomanometer every 5 minutes for 20 minutes before, and for 120 minutes after meal intake, with the participant in a sitting position.
Investigators will identify the nadir of SBP during the 120-minute postprandial period.
The magnitude of the drop in SBP will be calculated by subtracting the nadir value from the resting baseline average value.
|
In-lab testing - Visit 2 - Day 1
|
|
Low-GI Diet on Post-meal Systolic Blood Pressure Change- Diet A- Day 1
Time Frame: Free-living condition - Diet A - Day 1
|
After the in-lab meal test, each participant will be fitted with an ambulatory blood pressure (ABP) monitoring (ABPM) device, the Spacelabs OnTrak device, which has been validated for use in assessing ABP.
The first measurement will be obtained at UAB to ensure proper function of the device.
Each participant's ABP will be monitored for a total of 3 days.
The monitors will be programmed to measure BP at 15-minute intervals during the daytime (while participants are awake, e.g., 6 am to 11 pm).
Participants will be instructed to keep the monitored arm steady and at heart level during each BP reading.
Investigators will utilize the menu checklist to identify the timing of each meal consumed.
The magnitude of the PPH will be calculated for each meal, by substracting the nadir of SBP within 2 hours after each meal from the average SBP before each meal.
|
Free-living condition - Diet A - Day 1
|
|
Low-GI Diet on Post-meal Systolic Blood Pressure Change- Diet A- Day 2
Time Frame: Free-living condition - Diet A - Day 2
|
After the in-lab meal test, each participant will be fitted with an ABPM device, the Spacelabs OnTrak device, which has been validated for use in assessing ABP.
The first measurement will be obtained at UAB to ensure proper function of the device.
The monitors will be programmed to measure BP at 15-minute intervals during the daytime (while participants are awake, e.g., 6 am to 11 pm).
Participants will be instructed to keep the monitored arm steady and at heart level during each BP reading.
Investigators will utilize the menu checklist to identify the timing of each meal consumed.
The magnitude of the PPH will be calculated for each meal, by substracting the nadir of SBP within 2 hours after each meal from the average SBP before each meal.
|
Free-living condition - Diet A - Day 2
|
|
Low-GI Diet on Post-meal Systolic Blood Pressure Change- Diet A- Day 3
Time Frame: Free-living condition - Diet A - Day 3
|
After the in-lab meal test, each participant will be fitted with an ABPM device, the Spacelabs OnTrak device, which has been validated for use in assessing ABP.
The first measurement will be obtained at UAB to ensure proper function of the device.
The monitors will be programmed to measure BP at 15-minute intervals during the daytime (while participants are awake, e.g., 6 am to 11 pm).
Participants will be instructed to keep the monitored arm steady and at heart level during each BP reading.
Investigators will utilize the menu checklist to identify the timing of each meal consumed.
The magnitude of the PPH will be calculated for each meal, by substracting the nadir of SBP within 2 hours after each meal from the average SBP before each meal.
|
Free-living condition - Diet A - Day 3
|
|
Low-GI Diet on Post-meal Systolic Blood Pressure Change- Diet B- Day 1
Time Frame: Free-living condition - Diet B - Day 1
|
After the in-lab meal test, each participant will be fitted with an ABPM device, the Spacelabs OnTrak device, which has been validated for use in assessing ABP.
The first measurement will be obtained at UAB to ensure proper function of the device.
The monitors will be programmed to measure BP at 15-minute intervals during the daytime (while participants are awake, e.g., 6 am to 11 pm).
Participants will be instructed to keep the monitored arm steady and at heart level during each BP reading.
Investigators will utilize the menu checklist to identify the timing of each meal consumed.
The magnitude of the PPH will be calculated for each meal, by substracting the nadir of SBP within 2 hours after each meal from the average SBP before each meal.
|
Free-living condition - Diet B - Day 1
|
|
Low-GI Diet on Post-meal Systolic Blood Pressure Change- Diet B- Day 2
Time Frame: Free-living condition - Diet B - Day 2
|
After the in-lab meal test, each participant will be fitted with an ABPM device, the Spacelabs OnTrak device, which has been validated for use in assessing ABP.
The first measurement will be obtained at UAB to ensure proper function of the device.
The monitors will be programmed to measure BP at 15-minute intervals during the daytime (while participants are awake, e.g., 6 am to 11 pm).
Participants will be instructed to keep the monitored arm steady and at heart level during each BP reading.
Investigators will utilize the menu checklist to identify the timing of each meal consumed.
The magnitude of the PPH will be calculated for each meal, by substracting the nadir of SBP within 2 hours after each meal from the average SBP before each meal.
|
Free-living condition - Diet B - Day 2
|
|
Low-GI Diet on Post-meal Systolic Blood Pressure Change- Diet B- Day 3
Time Frame: Free-living condition - Diet B - Day 3
|
After the in-lab meal test, each participant will be fitted with an ABPM device, the Spacelabs OnTrak device, which has been validated for use in assessing ABP.
The first measurement will be obtained at UAB to ensure proper function of the device.
The monitors will be programmed to measure BP at 15-minute intervals during the daytime (while participants are awake, e.g., 6 am to 11 pm).
Participants will be instructed to keep the monitored arm steady and at heart level during each BP reading.
Investigators will utilize the menu checklist to identify the timing of each meal consumed.
The magnitude of the PPH will be calculated for each meal, by substracting the nadir of SBP within 2 hours after each meal from the average SBP before each meal.
|
Free-living condition - Diet B - Day 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Low-GI diet on postprandial glycemia- Visit 1
Time Frame: In-Lab testing - Visit 1 - Day 1
|
The investigators will obtain blood samples to assess blood sugar and insulin responses to the study diet throughout the in-lab testing period.
An intravenous catheter will be in an antecubital vein for blood draws 10 minutes before and 10, 30, 60, 90, and 120 minutes after meal consumption.
|
In-Lab testing - Visit 1 - Day 1
|
|
Low-GI diet on postprandial glycemia - Visit 2
Time Frame: In-Lab testing - Visit 2 - Day 1
|
The investigators will obtain blood samples to assess blood sugar and insulin responses to the study diet throughout the in-lab testing period.
An intravenous catheter will be in an antecubital vein for blood draws 10 minutes before and 10, 30, 60, 90, and 120 minutes after meal consumption.
|
In-Lab testing - Visit 2 - Day 1
|
|
Low-GI Diet on Postprandial Glucose Responses
Time Frame: Free-living condition - Diet A - Day 2
|
After the standard lab meal test, an FDA-approved CGM device (Dexcom G6 Pro, Dexcom, Inc.) will be placed in the back of each participant's arm to automatically measure glucose every 5 minutes during the 3-day study period.
Postprandial peak glucose concentration and glucose area under the curve within 2 hours after each meal will be identified and calculated (mealtime will be recorded on the menu checklist by each participant or their caregiver).
|
Free-living condition - Diet A - Day 2
|
|
Low-GI Diet on Postprandial Glucose Responses
Time Frame: Free-living condition - Diet A - Day 3
|
After the standard lab meal test, an FDA-approved CGM device (Dexcom G6 Pro, Dexcom, Inc.) will be placed in the back of each participant's arm to automatically measure glucose every 5 minutes during the 3-day study period.
Postprandial peak glucose concentration and glucose area under the curve within 2 hours after each meal will be identified and calculated (mealtime will be recorded on the menu checklist by each participant or their caregiver).
|
Free-living condition - Diet A - Day 3
|
|
Low-GI Diet on Postprandial Glucose Responses
Time Frame: Free-living condition - Diet B - Day 2
|
After the standard lab meal test, an FDA-approved CGM device (Dexcom G6 Pro, Dexcom, Inc.) will be placed in the back of each participant's arm to automatically measure glucose every 5 minutes during the 3-day study period.
Postprandial peak glucose concentration and glucose area under the curve within 2 hours after each meal will be identified and calculated (mealtime will be recorded on the menu checklist by each participant or their caregiver).
|
Free-living condition - Diet B - Day 2
|
|
Low-GI Diet on Postprandial Glucose Responses
Time Frame: Free-living condition - Diet B - Day 3
|
After the standard lab meal test, an FDA-approved CGM device (Dexcom G6 Pro, Dexcom, Inc.) will be placed in the back of each participant's arm to automatically measure glucose every 5 minutes during the 3-day study period.
Postprandial peak glucose concentration and glucose area under the curve within 2 hours after each meal will be identified and calculated (mealtime will be recorded on the menu checklist by each participant or their caregiver).
|
Free-living condition - Diet B - Day 3
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jia Li, PhD, The University of Alabama at Birmingham Department of Physical Medicine and Rehabilitation
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300008930
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Metabolism Disorders
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
RenJi HospitalGuangdong Provincial People's Hospital; Shanghai First Maternity and Infant... and other collaboratorsEnrolling by invitationPCOS | IVF Outcome | Glucose Metabolism DisorderChina
-
University of PlymouthRecruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom
-
University of LeipzigInstitut für Gesundheits- und Praxismanagement GmbHWithdrawn
-
Purdue UniversityAlmond Board of CaliforniaActive, not recruitingGlucose Intolerance | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States
-
University of South CarolinaCompletedPhysical Activity | Sedentary Lifestyle | Metabolism Disorder, GlucoseUnited States
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
DLR German Aerospace CenterCompletedGlucose Metabolism Disorders | Local Glucose Uptake
-
Wake Forest University Health SciencesNot yet recruitingGlucose Metabolism Disorders (Including Diabetes Mellitus)United States
Clinical Trials on Low-GI Diet
-
University of CopenhagenThe Danish Dairy Research Foundation, Denmark; Nordea-Fonden, Denmark; LEGO Charity... and other collaboratorsActive, not recruitingObesity | Pregnancy | Gestational Age and Weight Conditions | Maternal Care for Excessive Fetal Growth | Metabolic DisordersDenmark
-
Federal University of VicosaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...CompletedType 2 Diabetes MellitusBrazil
-
Maastricht University Medical CenterUnilever R&DCompletedObesity | Diet, Healthy | Fatty Liver, NonalcoholicNetherlands
-
Chinese University of Hong KongCompletedObesity | Central ObesityHong Kong
-
University of TorontoCompletedGestational DiabetesCanada
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Diseases | OverweightUnited States
-
Isfahan University of Medical SciencesCompletedDiabetic Nephropathy | Medication ComplianceIran, Islamic Republic of
-
University of Massachusetts, WorcesterCompletedLow-GI Dietary Education | ADA Dietary EducationUnited States
-
Peking Union Medical College HospitalUnknown
-
University Hospital of the West IndiesCompletedInflammation | Cardiovascular Disease | Type 2 DiabetesJamaica